The costs and benefits of screening for PKU in Wisconsin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003134:Commitment of Persons with Psychiatric Disorders / Q000191:economics; D003362:Cost-Benefit Analysis; D004495:Education of Persons with Intellectual Disabilities / Q000191:economics; D005260:Female; D005581:Foster Home Care / Q000191:economics; D030342:Genetic Diseases, Inborn; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007326:Institutionalization / Q000191:economics; D008607:Intellectual Disability / Q000209:etiology; D037141:Mandatory Programs; D008403:Mass Screening; D008875:Middle Aged; D010649:Phenylalanine / Q000097:blood; D010661:Phenylketonurias / Q000150:complications / Q000175:diagnosis*; D014922:Wisconsin
D010649:Phenylalanine